Top 50 Biopharma Products 2011

Ronald A. Rader, president of the Biotechnology Information Institute provided Contract Pharma a list of the Top 57 Biopharma Products by 2011 revenues (in millions). Mr. Rader subscribes to the sam...

Abbott Gets Approval For Liquid Injection Of Synagis For RS-Virus Prevention

Abbott Japan announced Aug. 15 that it has received approval for the liquid injection of Synagis (palivizumab) for the prevention of respiratory tract virus.

Human medicines European Public Assessment Report (EPAR): Synagis, palivizumab, Revision: 19, Authorised

Human medicines European Public Assessment Report (EPAR): Synagis, palivizumab, Revision: 22, Authorised

Human medicines European Public Assessment Report (EPAR): Synagis, palivizumab, Revision: 20, Authorised

Study In Journal of Medical Economics Shows Palivizumab Cost Effectiveness Using FDA-approved Dosing And AAP Red Book

GAITHERSBURG, Md., Oct. 3, 2012 /PRNewswire/ -- MedImmune, the biologics arm of AstraZeneca, today announced that the Journal of Medical Economics has published a study that shows Synagis® (paliv...

Study in Journal of Medical Economics Shows Palivizumab Cost Effectiveness Using FDA-Approved Dosing and APP Red Book

GAITHERSBURG, MD, October 3, 2012 – MedImmune, the biologics arm of AstraZeneca, today announced that the Journal of Medical Economics has published a study that shows Synagis® (palivizumab)...

Top 100 Drug Sales Data Released - Plavix Leads the Way

NEW YORK, July 18, 2012 /PRNewswire/ -- Drugs.com, the leading online clinical drug resource, today released first quarter 2012 U.S. prescription sales data for the top 100 drugs. Blood-thinners, pr...

Drugs.com Releases Q1 Sales for Top 100 U.S. Drugs: Rough U.S Flu Season Boosts Numbers for Tamiflu

NEW YORK, May 6, 2013 /PRNewswire/ -- Drugs.com, the leading online clinical drug resource, today released first quarter 2013 U.S. prescription sales data for the top 100 drugs. (Photo:  http://...

WITHDRAWN: Immunoglobulin treatment for respiratory syncytial virus infection.

BACKGROUND: Respiratory syncytial virus (RSV) bronchiolitis and pneumonia hospitalise hundreds of thousands of infants every year. Treatment is largely supportive therapy, (for example, oxygen, fluids...